Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10

Showing 10 citing articles:

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
Daniele Focosi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 9, pp. 1999-1999
Open Access | Times Cited: 52
Molnupiravir: From Hope to Epic Fail?
Daniele Focosi
Viruses (2022) Vol. 14, Iss. 11, pp. 2560-2560
Open Access | Times Cited: 25
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
Massimo Franchini, Arturo Casadevall, Michael J. Joyner, et al.
Life (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 9
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Daniele Focosi, Massimo Franchini
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103648-103648
Open Access | Times Cited: 4
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, et al.
BMJ Open (2023) Vol. 13, Iss. 4, pp. e071277-e071277
Open Access | Times Cited: 4
Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses
Daniele Focosi, Jonathon W. Senefeld, Michael J. Joyner, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 2
Open Access | Times Cited: 7
Convalescent plasma in oncohematological patients
Daniele Focosi, Massimo Franchini, Michael J. Joyner, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 208-209
Open Access | Times Cited: 2
On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
Daniele Focosi, Massimo Franchini, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 11, pp. 2378-2378
Open Access | Times Cited: 2
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe
Daniele Focosi, Massimo Franchini
Life (2022) Vol. 12, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 1
Page 1

Scroll to top